Sign In
Buy CGEN
$2.19
-0.0700 (-3.10%)
At Close: Jun 03, 2026
7 Speculative Stocks to Double Your Money THIS Year
10:14pm, Monday, 22'nd Jan 2024
While investors should probably direct the majority of their market-earmarked funds toward slow-and-steady ideas – à la Warren Buffett – sometimes, we end up with gambling money. And in that case
iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must Watch
08:01am, Wednesday, 10'th Jan 2024
iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must Watch
HOLON, Israel , Jan. 8, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced t
Compugen Regains Compliance with Nasdaq Minimum Bid Price Requirement
07:00am, Monday, 08'th Jan 2024
HOLON, Israel , Jan. 8, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today t
Gilead Sciences and Compugen strike commercialization deal for immunotherapy program
11:31am, Wednesday, 20'th Dec 2023
Gilead Sciences, Inc. (NASDAQ:GILD) announced that it has entered into an agreement with Compugen Ltd (NASDAQ:CGEN) to exclusively license Compugen's pre-clinical antibody program against IL-18 bindi
Why Are Stocks Up Today?
10:23am, Tuesday, 19'th Dec 2023
Stocks are up today and investors wondering why will want to keep reading as we have a breakdown of the market's rally on Tuesday! The big catalyst keeping stocks up today comes from high investor hop
Why Is Compugen (CGEN) Stock Up 189% Today?
10:11am, Tuesday, 19'th Dec 2023
Compugen (NASDAQ: CGEN ) stock is rocketing higher on Tuesday after announcing an exclusive licensing agreement with Gilead Sciences (NASDAQ: GILD ). According to a press release from Compugen, this a
Compugen stock rockets on anti-tumor drug deal with Gilead
07:13am, Tuesday, 19'th Dec 2023
Compugen Ltd.'s stock CGEN, -3.36% was up by 113% in premarket trading on Tuesday after the company said it agreed to sell exclusive rights to Gilead Sciences Inc. GILD, -1.03% for later stage develop
Conference call today, December 19, 2023, 8:30 AM ET to discuss the license agreement HOLON, Israel , Dec. 19, 2023 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer im
7 Promising Penny Stocks With the Potential to Defy Expectations
08:17am, Friday, 15'th Dec 2023
You know you want it. High-potential penny stocks that is.
Is Compugen (CGEN) Outperforming Other Medical Stocks This Year?
11:18am, Tuesday, 05'th Dec 2023
Here is how Compugen (CGEN) and Evogene (EVGN) have performed compared to their sector so far this year.
These Israeli pharmaceutical stocks are down in the wake of Hamas attack
08:53am, Monday, 09'th Oct 2023
Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on Israel.
Has Compugen (CGEN) Outpaced Other Medical Stocks This Year?
11:17am, Tuesday, 29'th Aug 2023
Here is how Compugen (CGEN) and Corcept Therapeutics (CORT) have performed compared to their sector so far this year.
Compugen Ltd. (CGEN) Q1 2023 Earnings Call Transcript
02:21pm, Monday, 15'th May 2023
Compugen Ltd. (NASDAQ:CGEN ) Q1 2023 Earnings Conference Call May 15, 2023 8:30 AM ET Company Participants Yvonne Naughton - Head of Investor Relations and Corporate Communications Anat Cohen-Dayag -
Compugen to Release First Quarter 2023 Results on Monday, May 15, 2023
07:00am, Monday, 01'st May 2023
HOLON, Israel , May 1, 2023 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced tha
